Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Deconinck, E. et al.

In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213).

The inhibitory effects of mafosfamide lysine, ASTA-Z 7654 (ASTA-Z) and etoposide, (VP16-213) on human leukemic progenitor cells (AML-CFU) were studied using a clonogenic assay. AML-CFU were shown to be less sensitive than human promyelocytic leukemia cells (HL-60) to the toxic effects of these two drugs. The mean log kill obtained for the AML-CFU from 12 patients was only 0.95 and 0.93 for 50 micrograms/ml ASTA-Z and etoposide respectively. For normal progenitor cells (CFU-GM) the maximum log kill increased to 2 log at 50 micrograms/ml ASTA-Z or etoposide and for HL-60 cells more than 4 log kill values were obtained for the same drug concentrations. When the two drugs were used in combination the log kill value increased to 1.75 for AML-CFU. Furthermore, in addition to classic incubation parameters (temperature, cell concentration, red blood cell contamination and time) the treatment efficiency was influenced by the incubation sequence of the two drugs. When ASTA-Z and etoposide were incubated together (Z/VP) or etoposide prior to ASTA-Z (VP + Z) log kill values for drug concentrations of 20 and 50 micrograms/ml were 0.72 and 1.41 respectively. However, when cells were incubated with ASTA-Z prior to etoposide (Z + VP) values of 1.1 and 1.75 were obtained for drug concentrations of 20 and 50 micrograms/ml respectively (p less than or equal to 0.05 between Z + VP and the two other sequences).(ABSTRACT TRUNCATED AT 250 WORDS)[1]

References

In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213). Deconinck, E., Tamayo, E., Hervé, P. Bone Marrow Transplant. (1990) [Pubmed]

Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.